Severe lung fibrosis after chemotherapy in a child with ataxia-telangiectasia [1]

Journal of Pediatric Hematology/Oncology

Volumn 24, Issue 1, 2002, Pages 77-79

  Chen, Rong Long ^a   Wang, Pen Jung ^a   Hsu, Yung Hsiung ^a   Chang, Pau Yuan ^a   Fang, Jye Siung ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; EPIRUBICIN; HYDROCORTISONE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ATAXIA TELANGIECTASIA; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; HUMAN; HUMAN TISSUE; LETTER; LUNG FIBROSIS; LYMPHOMA; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ATAXIA TELANGIECTASIA; BURKITT LYMPHOMA; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; PULMONARY FIBROSIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0036156227     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200201000-00021     Document Type: Letter

References (8)

1. Consequences of the delayed diagnosis of ataxia-telangiectasia
2. Lymphoid malignancy as a presenting sign of ataxia-telangiectasia
3. Lung function following treatment of malignant tumors with surgery, radiotherapy, or cyclophosphamide in childhood. A follow-up study after 11 to 27 years
4. Limiting therapy for limited childhood non-Hodgkin's lymphoma
5. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma
6. Ataxia-telangiectasia: A familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection
7. Protective roles for ATM in cellular response to oxidative stress
8. Intermediate-dose busulfan and cyclophosphamide as a conditioning regimen for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation